Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Twelve Bio logo — Twelve Bio has developed a diagnostic tool using CRISPR-Cas1...

Twelve Bio

Twelve Bio has developed a diagnostic tool using CRISPR-Cas12a to detect and modify DNA sequences.

Founded 2019 Grant Total: $519.00K Analytics, Biotechnology +1

General Information

Company Name Twelve Bio
Founded Year 2019
Industries Analytics, Biotechnology, Health Care
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Twelve Bio. To contact Twelve Bio, visit twelve.bio.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Twelve Bio compare?

A PDF of Twelve Bio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Twelve Bio soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Twelve Bio

Twelve Bio is a biotechnology startup founded in 2019, offering a groundbreaking diagnostic tool utilizing CRISPR-Cas12a technology to detect and modify DNA sequences.

Twelve Bio specializes in the development of diagnostic technology using CRISPR-Cas12a, capable of detecting and modifying any DNA sequence. The CRISPR-Cas12a system encompasses an RNA-protein complex that enables the identification and modification of specific DNA sequences. The RNA component acts as a search engine to pinpoint the specific DNA sequence, while the protein functions as a biological scissor to cleave it. Leveraging their structural-based rational design insights into the CRISPR gene editing system, Twelve Bio can manipulate and refine the system's activity to meet therapeutic objectives effectively.

The company received a significant $519.00K grant investment on 1st November 2019. This investment underlines the potential and promise of Twelve Bio's innovative approach within the biotechnology industry. With dedicated efforts and visionary technology, Twelve Bio is on a trajectory to revolutionize the field of genetic diagnostics and therapeutics.

Business keywords: CRISPR-Cas12a, diagnostic technology, DNA sequencing, gene editing, RNA-protein complex, structural-based design, therapeutic objectives

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $519.00K -
01 Nov 2019

Twelve Bio Alternatives & Competitors

View All Alternatives
Twelve Bio vs
Integrated DNA Technologies
Integrated DNA Technologies United States

Lab to life-changing advances. We’ll help.

Acquired
1771 employees
Biotechnology, Health Care
Twelve Bio vs
Synbio Technologies
Synbio Technologies United States

Changing the world, one sequence at a time.

25 employees
Biotechnology, Health Care
Twelve Bio vs
Twist Bioscience
Twist Bioscience United States

Synthetic DNA for Health & Sustainability

IPO
1317 employees
Biotechnology, Health Care
View all alternatives

FAQ About Twelve Bio

Twelve Bio has developed a diagnostic tool using CRISPR-Cas12a to detect and modify DNA sequences.
Twelve Bio was founded in 2019.
Twelve Bio operates in Analytics, Biotechnology and Health Care. Its work centres on CRISPR-Cas12a, diagnostic technology, DNA sequencing and gene editing.
Twelve Bio has completed 1 funding round, raising a total of $519.00K. The latest funding stage is Grant.
Top alternatives and competitors to Twelve Bio include Integrated DNA Technologies, Synbio Technologies, Twist Bioscience, Integra Therapeutics, EdiGene Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Twelve Bio and Integrated DNA Technologies are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Twelve Bio, https://bouncewatch.com/company/twelve-bio, updated 1 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes